(Q40413880)
Statements
Tolerability and safety profile of 12- to 28-week treatment with interferon beta-1b 250 and 500 microg QOD in patients with relapsing-remitting multiple sclerosis: a multicenter, randomized, double-blind, parallel-group pilot study (English)
Barrie J Hurwitz
Douglas Jeffery
Barry Arnason
Kim Bigley
Patricia Coyle
Douglas Goodin
Samer Kaba
Stephen Kirzinger
Sharon Lynch
Raul Mandler
Daniel Mikol
Kottil Rammohan
Richard Sater
Subramaniam Sriram
Ben Thrower
Francis Boateng
Peter Jakobs
Mary Beth Wash